ArticleJournal of Cancer2020

A Study of the S-1 or Capecitabine as First-line Regimen in Patients with Metastatic Colorectal Cancer: A Real World Study.

Yanan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.